What it is
NAD+ (nicotinamide adenine dinucleotide) is a small molecule your body already makes and uses in every cell. It is a coenzyme — a helper molecule that hundreds of enzymes need in order to do their jobs, especially turning food into usable cellular energy. Strictly speaking it is not a peptide (it has no amino acids or peptide bonds), but it is often sold and discussed alongside research peptides, so we cover it here.
Levels of NAD+ fall substantially as people age and during metabolic stress. That age-related decline is why NAD+ has become a focus of longevity and 'healthy aging' research. Materials are sold as raw powder or in IV/injectable form, typically labeled 'for laboratory research use only.'
Because directly raising NAD+ by swallowing it is inefficient (it breaks down in digestion), most human research uses precursors the body converts into NAD+ — chiefly NMN and NR.
How it works
NAD+ shuttles electrons during metabolism, making it central to converting carbohydrates, fats, and proteins into ATP (cellular energy). It also acts as fuel or substrate for two important enzyme families: sirtuins, which help regulate gene expression and metabolic health, and PARPs, which are involved in repairing damaged DNA. Because these enzymes consume NAD+ as they work, cellular demand for NAD+ can outpace supply — especially with age.
You cannot efficiently 'top up' NAD+ by eating it directly, so most approaches supply precursors — NR and NMN — that cells convert into NAD+ through a short salvage pathway. This is a key honesty point: the strongest human data comes from these oral precursors, not from directly injected or infused NAD+, which is far less studied in controlled trials.
What people research it for
Reliably raises blood NAD+ levels
Human studiesIn an 8-week randomized placebo-controlled trial, NR raised whole-blood NAD+ dose-dependently (about 22%, 51%, and 142% at 100, 300, and 1000 mg/day). This 'target engagement' is the best-established effect in humans.
Possible metabolic / insulin-sensitivity signals
Early human dataA small trial in prediabetic women reported improved insulin sensitivity with NMN, but other metabolic trials found no clear benefit. Results are mixed and preliminary.
Physical performance / muscle function
Early human dataSome NMN trials reported modest gains in gait speed, grip strength, or aerobic measures in older or trained adults, though effects are inconsistent across studies.
Lifespan and healthspan extension
Animal studiesRestoring NAD+ extended lifespan or improved healthspan in mice, worms, and other models. These striking longevity results have not been replicated in humans.
What the research actually shows
Most rigorous human evidence involves the precursors NR and NMN, not injected NAD+. Randomized trials show these compounds safely and meaningfully raise blood NAD+ within weeks. That much is well-supported.
The leap from 'raises NAD+' to 'makes you healthier or live longer' is where evidence thins out. Human trials have been small, short (often under 12 weeks), and mixed — some promising signals in prediabetes, Parkinson's, or peripheral artery disease, but many neutral results in metabolic endpoints. The dramatic anti-aging outcomes seen in mice have not been shown in people.
Bottom line: the longevity marketing runs well ahead of the human data. NAD+ biology is real and important, but claims that NAD+ or its precursors slow human aging remain unproven and await large, long-term trials.
Research handling & storage
Research-use NAD+ and NMN are typically supplied as a white crystalline powder that is hygroscopic (absorbs moisture) and heat- and light-sensitive. Powders are generally stored cold and dry, protected from light; reconstituted or IV solutions are far less stable and degrade over time.
In non-research settings NAD+ is marketed via IV drips and subcutaneous injection, and its precursors as oral capsules. IV NAD+ is popular in wellness clinics but is the least studied delivery route in controlled trials, and product purity varies widely between vendors — a reason lab testing / COA verification matters when comparing sources.
Safety & cautions
In human trials the oral precursors NR and NMN have generally been well tolerated at the doses tested, with no serious adverse events and, for NR specifically, no flushing and no adverse changes in cholesterol. Reported side effects tend to be mild and comparable to placebo. However, trials were short and small, so long-term safety is not established.
IV or injectable NAD+ is a different picture: infusions are commonly associated with flushing, nausea, chest tightness, and discomfort, especially when given quickly, and injections carry the usual injection-site risks. Neither IV NAD+ nor NMN is an FDA-approved drug for any condition, and research-labeled material is not intended for human use.
Track NAD+ prices
Get an alert when a trusted, tested vendor drops the price. Free.
Frequently asked questions
Is NAD+ FDA approved?
No. Neither NAD+ (IV or injectable) nor its precursors NMN and NR are FDA-approved drugs for treating, curing, or preventing any disease. Materials sold 'for research use only' are not intended for human consumption.
Is NMN legal to sell as a supplement?
The status has shifted. In 2022 the FDA excluded NMN from the dietary-supplement definition after it was under investigation as a new drug (MIB-626). In 2025 the FDA reversed course and indicated NMN can lawfully be sold as a dietary supplement again. Regulations continue to evolve.
What's the difference between NAD+, NMN, and NR?
NAD+ is the active coenzyme itself. NMN and NR are precursors — building blocks the body converts into NAD+. NR is one step further 'upstream' than NMN. Most solid human trial data comes from NR and NMN rather than from directly dosing NAD+.
Does NAD+ actually make you live longer?
There is no human evidence for that. Lifespan extension has been seen in animals like mice and worms, but human trials are short, small, and mixed. The longevity claims are largely theorized or extrapolated from animal work.
Is IV NAD+ better than oral precursors?
Not according to the evidence. IV NAD+ is heavily marketed but is the least studied route in controlled trials. The best-documented, safest way to raise NAD+ in humans so far is oral NR or NMN.
Sources
- Conze et al., 2019 — NR (NIAGEN) randomized placebo-controlled trial, Scientific Reports (via NIH PMC)
- Song et al., 2023 — Safety and Antiaging Effects of NMN in Human Clinical Trials, Advances in Nutrition (NIH PMC)
- Oral NMN is safe and increases blood NAD+ in healthy subjects (NIH PMC)
- Marketers say NAD+ pills and infusions can boost longevity — what's the evidence? (NPR, 2026)
Last reviewed 2026-07-07. This guide is educational and research-focused — not medical advice. NAD+ products referenced on PeptidePub are sold by third parties as materials for laboratory research use only, not for human or animal consumption.
Related peptides
Ready to compare NAD+?
See prices across trusted, third-party-tested vendors, normalized per milligram.
Compare NAD+ prices →